Immunology
-
Computationally Optimized SARS-CoV-2 MHC Class I and II Vaccine Formulations Predicted to Target Human Haplotype Distributions
This article has 7 authors:Reviewed by ScreenIT
-
Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors
This article has 18 authors:Reviewed by ScreenIT
-
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein
This article has 37 authors:Reviewed by ScreenIT
-
CoV-AbDab: the coronavirus antibody database
This article has 4 authors:Reviewed by ScreenIT
-
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement
This article has 13 authors:Reviewed by ScreenIT
-
Predicting the Immunogenicity of T cell epitopes: From HIV to SARS-CoV-2
This article has 7 authors:Reviewed by ScreenIT
-
Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome
This article has 4 authors:Reviewed by ScreenIT
-
Novel ACE2-Independent Carbohydrate-Binding of SARS-CoV-2 Spike Protein to Host Lectins and Lung Microbiota
This article has 11 authors:Reviewed by ScreenIT
-
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
This article has 31 authors:Reviewed by ScreenIT
-
Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual
This article has 19 authors:Reviewed by ScreenIT